We are live on ! Find out more
Deutsche Bank

Deutsche Bank Portfolio holdings

AUM $303B
1-Year Est. Return 30.15%
 

Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.

This Fund
S&P 500
This Quarter Est. Return
+9.01%
1 Year Est. Return
+30.15%
3 Year Est. Return
+94.64%
5 Year Est. Return
+128.65%
10 Year Est. Return
+466.74%
AUM
$153B
AUM Growth
+$9.45B
Cap. Flow
-$5.3B
Cap. Flow %
-3.45%
Top 10 Hldgs %
17.22%
Holding
5,318
New
407
Increased
2,249
Reduced
1,924
Closed
262

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$333M
2
BABA icon
Alibaba
BABA
+$303M
3
PFE icon
Pfizer
PFE
+$269M
4
MSFT icon
Microsoft
MSFT
+$264M
5
ES icon
Eversource Energy
ES
+$255M

Sector Composition

Rank Sector Weight
1 Technology 15.66%
2 Healthcare 13.63%
3 Financials 11.69%
4 Communication Services 9.98%
5 Consumer Discretionary 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIOT
3776
Viomi Technology
VIOT
$50.6M
$55K ﹤0.01%
+6,930
New +$59.7K
ENZ
3777
DELISTED
Enzo Biochem, Inc.
ENZ
$55K ﹤0.01%
21,329
+9,723
+84% +$29K
TCRR
3778
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$55K ﹤0.01%
3,902
+801
+26% +$12.4K
ZEN
3779
PUT
DELISTED
ZENDESK INC
ZEN
$55K ﹤0.01%
720
ANGL icon
3780
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.06B
$54K ﹤0.01%
1,841
+456
+33% +$13.4K
AVGO icon
3781
CALL
Broadcom
AVGO
$2.01T
$54K ﹤0.01%
1,730
-1,930
-53% -$58.6K
CASI
3782
DELISTED
CASI Pharmaceuticals
CASI
$54K ﹤0.01%
1,798
+346
+24% +$11.2K
KNSA icon
3783
Kiniksa Pharmaceuticals
KNSA
$6.03B
$54K ﹤0.01%
4,973
+1,121
+29% +$9.74K
MNSB icon
3784
MainStreet Bancshares
MNSB
$167M
$54K ﹤0.01%
2,365
+259
+12% +$5.64K
PLSE icon
3785
Pulse Biosciences
PLSE
$2.55B
$54K ﹤0.01%
4,069
+777
+24% +$11.1K
REI icon
3786
Ring Energy
REI
$315M
$54K ﹤0.01%
20,765
+4,311
+26% +$8.46K
VMD icon
3787
Viemed Healthcare
VMD
$366M
$54K ﹤0.01%
+8,800
New +$61K
WEYS icon
3788
Weyco Group
WEYS
$402M
$54K ﹤0.01%
2,042
-934
-31% -$23.1K
CBNK icon
3789
Capital Bancorp
CBNK
$615M
$53K ﹤0.01%
3,644
+212
+6% +$3.01K
CGEN icon
3790
Compugen
CGEN
$218M
$53K ﹤0.01%
+8,991
New +$46.3K
FRAF icon
3791
Franklin Financial Services
FRAF
$286M
$53K ﹤0.01%
1,390
+166
+14% +$6.05K
HFFG icon
3792
HF Foods Group
HFFG
$78.1M
$53K ﹤0.01%
2,755
+185
+7% +$3.68K
SBR
3793
Sabine Royalty Trust
SBR
$1.03B
$53K ﹤0.01%
1,317
-41
-3% -$1.62K
XOM icon
3794
CALL
ExxonMobil
XOM
$632B
$53K ﹤0.01%
772
-50
-6% -$3.46K
SRGA
3795
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$53K ﹤0.01%
657
+87
+15% +$6.1K
FPRX
3796
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$53K ﹤0.01%
11,903
-20,094
-63% -$79.6K
VIE
3797
DELISTED
Viela Bio, Inc. Common Stock
VIE
$53K ﹤0.01%
+2,006
New +$50.6K
CCH.U
3798
DELISTED
Collier Creek Holdings Units, each consisting of one Class A ordinary share, $0.0001 par value, and
CCH.U
$53K ﹤0.01%
5,000
-495,000
-99% -$5.31M
LOVE
3799
LoveSac
LOVE
$276M
$52K ﹤0.01%
3,310
+877
+36% +$13.7K
NGS icon
3800
Natural Gas Services Group
NGS
$475M
$52K ﹤0.01%
4,291
-4,162
-49% -$49K

Similar funds

Deutsche Bank's Q4 2019 Portfolio in Review

As of Q4 2019, Deutsche Bank held 5,318 positions worth $153B, up 6.6% from $144B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Deutsche Bank withdrew a net $5.3B in Q4 2019, closing 262 positions and reducing 1,924 holdings. Its most notable exit was Celgene Corp, an estimated $273M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Deutsche Bank opened a new position in XP worth $32.9M.

  • Deutsche Bank's largest Q4 2019 buy was XP: 853,950 shares worth $32.9M.
  • Deutsche Bank added most to Johnson & Johnson in Q4 2019, an estimated $333M increase.
  • Deutsche Bank's biggest Q4 2019 reduction was Vanguard Morningstar Growth ETF, cutting an estimated $780M.
  • Deutsche Bank fully exited Celgene Corp in Q4 2019, selling an estimated $273M.
  • Deutsche Bank's ten largest holdings make up 17% of its $153B portfolio in Q4 2019.
  • Deutsche Bank opened 407 new positions and closed 262 in Q4 2019.
  • Deutsche Bank's portfolio value rose 6.6% quarter-over-quarter to $153B.

Based on Deutsche Bank's 13F filing for Q4 2019, filed 14 Feb 2020.